Multilevel Determinants of COVID-19 Vaccination Hesitancy in the United States: A Rapid Systematic Review

Overview

Journal Prev Med Rep

Date 2021 Dec 22

PMID 34934611

Citations 59

Authors

Ying Wang

Yu Liu

Affiliations

Soon will be listed here.

Abstract

Vaccine hesitancy is a challenge for the success and optimal implementation of COVID-19 immunization programs in the US. The objective of this study was to summarize multilevel determinants of COVID-19 vaccination intention in the US to inform future intervention opportunities. To this end, we conducted a rapid systematic review by searching published articles via PubMed published by October 5, 2021, following the PRISMA guidelines. One hundred and six articles were included. According to nationally representative studies, the overall COVID-19 acceptance rate ranges from 53.6% to 84.4%. Individual (demographics, health history, behaviors and health beliefs), interpersonal (having a close friend/family member impacted by COVID-19), healthcare and societal level factors (healthcare provider recommendations, source/credential of COVID-19 related information, and COVID-19 related conspiracy theories) all contributed to COVID-19 vaccine hesitancy in the US. This study demonstrates that the acceptance to COVID-19 vaccines is influenced by various factors, particularly the role of healthcare providers in enhancing public intent to vaccination. Potential interventions to mitigate people's concerns over the vaccines and address vaccine-related conspiracy/misinformation from social media are also critical to encourage vaccine uptake in the US.

Citing Articles

Development of prediction models of COVID-19 vaccine uptake among Lebanese and Syrians in a district of Beirut, Lebanon: a population-based study.

Ragi M, Ghattas H, Shamas H, DeJong J, Melhem N, McCall S BMJ Public Health. 2025; 2(2):e001240.

PMID: 40018546 PMC: 11816316. DOI: 10.1136/bmjph-2024-001240.

Vaccine Hesitancy and Associated Factors Amongst Health Professionals: A Scoping Review of the Published Literature.

Christodoulakis A, Bouloukaki I, Aravantinou-Karlatou A, Zografakis-Sfakianakis M, Tsiligianni I Vaccines (Basel). 2025; 12(12).

PMID: 39772072 PMC: 11680286. DOI: 10.3390/vaccines12121411.

COVID-19 vaccine booster willingness among Asian Americans: Influence of racial discrimination and social determinants.

Li Q, Subica A Hum Vaccin Immunother. 2024; 20(1):2417520.

PMID: 39462523 PMC: 11520532. DOI: 10.1080/21645515.2024.2417520.

Vaccine hesitancy in context of COVID-19 in East Africa: systematic review and meta-analysis.

Alie M, Abebe G, Negesse Y, Adugna A, Girma D BMC Public Health. 2024; 24(1):2796.

PMID: 39395943 PMC: 11470748. DOI: 10.1186/s12889-024-20324-z.

Prevalence of COVID-19 vaccine hesitancy in students: A global systematic review.

Nath Roy D, Hossen M, Biswas M, Islam E, Azam M F1000Res. 2024; 11:928.

PMID: 39290373 PMC: 11406128. DOI: 10.12688/f1000research.122815.1.

References

Tenforde M, Olson S, Self W, Talbot H, Lindsell C, Steingrub J . Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021. MMWR Morb Mortal Wkly Rep. 2021; 70(18):674-679. PMC: 9368749. DOI: 10.15585/mmwr.mm7018e1. View

Burke P, Masters D, Massey G . Enablers and barriers to COVID-19 vaccine uptake: An international study of perceptions and intentions. Vaccine. 2021; 39(36):5116-5128. PMC: 8299222. DOI: 10.1016/j.vaccine.2021.07.056. View

Agley J, Xiao Y, Thompson E, Golzarri-Arroyo L . Factors associated with reported likelihood to get vaccinated for COVID-19 in a nationally representative US survey. Public Health. 2021; 196:91-94. PMC: 8157318. DOI: 10.1016/j.puhe.2021.05.009. View

Aw J, Seng J, Seah S, Low L . COVID-19 Vaccine Hesitancy-A Scoping Review of Literature in High-Income Countries. Vaccines (Basel). 2021; 9(8). PMC: 8402587. DOI: 10.3390/vaccines9080900. View

Ma Z, Ma R . Predicting Intentions to Vaccinate against COVID-19 and Seasonal Flu: The Role of Consideration of Future and Immediate Consequences. Health Commun. 2021; 37(8):952-961. DOI: 10.1080/10410236.2021.1877913. View

Kelekar A, Lucia V, Afonso N, Mascarenhas A . COVID-19 vaccine acceptance and hesitancy among dental and medical students. J Am Dent Assoc. 2021; 152(8):596-603. PMC: 7997309. DOI: 10.1016/j.adaj.2021.03.006. View

Harhay M, Klassen A, Zaidi H, Mittelman M, Bertha R, Mannon R . Living Organ Donor Perspectives and Sources of Hesitancy about COVID-19 Vaccines. Kidney360. 2021; 2(7):1132-1140. PMC: 8323843. DOI: 10.34067/KID.0002112021. View

Gadoth A, Halbrook M, Martin-Blais R, Gray A, Tobin N, Ferbas K . Cross-sectional Assessment of COVID-19 Vaccine Acceptance Among Health Care Workers in Los Angeles. Ann Intern Med. 2021; 174(6):882-885. PMC: 7926184. DOI: 10.7326/M20-7580. View

Sherman S, Smith L, Sim J, Amlot R, Cutts M, Dasch H . COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey. Hum Vaccin Immunother. 2020; 17(6):1612-1621. PMC: 8115754. DOI: 10.1080/21645515.2020.1846397. View

10.

Shallal A, Abada E, Musallam R, Fehmi O, Kaljee L, Fehmi Z . Evaluation of COVID-19 Vaccine Attitudes among Arab American Healthcare Professionals Living in the United States. Vaccines (Basel). 2021; 9(9). PMC: 8471462. DOI: 10.3390/vaccines9090942. View

11.

Doherty I, Pilkington W, Brown L, Billings V, Hoffler U, Paulin L . COVID-19 vaccine hesitancy in underserved communities of North Carolina. PLoS One. 2021; 16(11):e0248542. PMC: 8559933. DOI: 10.1371/journal.pone.0248542. View

12.

Rungkitwattanakul D, Yabusaki A, Singh D, Lawson P, Nwaogwugwu U, Iheagwara O . COVID-19 vaccine hesitancy among African American hemodialysis patients: A single-center experience. Hemodial Int. 2021; . PMC: 8250524. DOI: 10.1111/hdi.12922. View

13.

Fisher K, Bloomstone S, Walder J, Crawford S, Fouayzi H, Mazor K . Attitudes Toward a Potential SARS-CoV-2 Vaccine : A Survey of U.S. Adults. Ann Intern Med. 2020; 173(12):964-973. PMC: 7505019. DOI: 10.7326/M20-3569. View

14.

Neely S, Eldredge C, Sanders R . Health Information Seeking Behaviors on Social Media During the COVID-19 Pandemic Among American Social Networking Site Users: Survey Study. J Med Internet Res. 2021; 23(6):e29802. PMC: 8202660. DOI: 10.2196/29802. View

15.

Lucia V, Kelekar A, Afonso N . COVID-19 vaccine hesitancy among medical students. J Public Health (Oxf). 2020; 43(3):445-449. PMC: 7799040. DOI: 10.1093/pubmed/fdaa230. View

16.

Loomba S, de Figueiredo A, Piatek S, de Graaf K, Larson H . Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA. Nat Hum Behav. 2021; 5(3):337-348. DOI: 10.1038/s41562-021-01056-1. View

17.

Di Fusco M, Shea K, Lin J, Nguyen J, Angulo F, Benigno M . Health outcomes and economic burden of hospitalized COVID-19 patients in the United States. J Med Econ. 2021; 24(1):308-317. DOI: 10.1080/13696998.2021.1886109. View

18.

Bogart L, Dong L, Gandhi P, Klein D, Smith T, Ryan S . COVID-19 Vaccine Intentions and Mistrust in a National Sample of Black Americans. J Natl Med Assoc. 2021; 113(6):599-611. PMC: 8214755. DOI: 10.1016/j.jnma.2021.05.011. View

19.

Patelarou A, Saliaj A, Galanis P, Pulomenaj V, Prifti V, Sopjani I . Predictors of nurses' intention to accept COVID-19 vaccination: A cross-sectional study in five European countries. J Clin Nurs. 2021; 31(9-10):1258-1266. PMC: 8446965. DOI: 10.1111/jocn.15980. View

20.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View